The aim of this project, emerged within the L2CM laboratory, is to develop a novel approach utilizing optical imaging to track the biotransformations of metal-based drug candidates in view of rationalizing their further pharmacomodulation. This will allow to establish a relationship between metal’s coordination sphere, metal-ligand interaction, and the complexes’ biotransformations to rationalize drug design. Web: Expires on Friday April 28th, 2023

Copper-Based Molecular Electrocatalyst for Strong C-H bond Activation The project will be developed within two groups (BIOCEN and CIRe) in DCM possessing complementary recognized expertise in chemical design and synthesis, characterization techniques, molecular electrochemistry and in functionalization of carbon-based nanomaterials. Expires on Wednesday April 5th, 2023